Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03097133
Brief Title: 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide (Aspire II)

First Submitted : March 27, 2017
First Submitted that Met QC Criteria : March 27, 2017
First Posted : March 31, 2017

Last Update Submitted that Met QC Criteria : October 9, 2019
Last Update Posted : October 11, 2019